Searching for Autologous Hematopoietic Stem Cell Support information? Find all needed info by using official links provided below.
https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hematology/autologous-hematopoietic-cell-transplantation-2/
Autologous hematopoietic cell transplantation (HCT) is the intravenous infusion of hematopoietic stem and progenitor cells designed to re-establish marrow and immune function in patients with a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673673/
Guidelines recommend vaccination starting 12 months after autologous hematopoietic stem cell transplant (aHCT), but there is varying practice for patients on maintenance therapy, with some centers not immunizing at all. Due to decreased vaccine rates ...Cited by: 5
https://www.sciencedirect.com/science/article/pii/S1083879104001107
The use of autologous hematopoietic stem cell transplantation (AHSCT) to abrogate prolonged hematologic toxicity allows a variable, but often considerable, degree of dose escalation of certain cytotoxic agents used for cancer therapy.Cited by: 78
https://cancer.osu.edu/research-and-education/find-a-scientific-publication/beam-versus-bucyvp16-conditioning-before-autologous-hematopoietic-stem-cell-transplant-in-patients-with-hodgkin-lymphoma
High-dose chemotherapy followed by autologous hematopoietic stem cell transplant (AHSCT) is a standard of care for patients with relapsed Hodgkin lymphoma. Different conditioning regimens before AHSCT have been used, with the 2 most common being BEAM (carmustine, etoposide, cytarabine, and
http://pathology.ucla.edu/workfiles/Education/Transfusion%20Medicine/14-2-Transfusion-Support-For-Hemotopoietic-Stem-Cell-Transplant.pdf
Post transplant : •Cytopenias: long term support •Immune suppression : risks of transfusion transmitted CMV infection, and TA-GVHD. Transfusion practices in this population primarily based on anectodotal reports of toxicities, institutional experiences, and common-sense understanding of the pathophysiology involved.
https://www.nature.com/articles/1700913
Sep 01, 1997 · One hundred and forty-eight patients with NHL (n = 112) or HD (n = 36) received BEAM followed by infusion of bone marrow (n = 55), peripheral blood stem cells (n = 79) or both (n = 14). Twenty-eight patients had low-grade lymphoma (LGL), 68 intermediate- …Cited by: 168
How to find Autologous Hematopoietic Stem Cell Support information?
Follow the instuctions below:
- Choose an official link provided above.
- Click on it.
- Find company email address & contact them via email
- Find company phone & make a call.
- Find company address & visit their office.
